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remains in obscurity but I trust 
that ere long further 
consideration will clear up the 
difficulty" 
Dalziel, T.K. (1913) 
British Medical Journal, ii, 1668 
It is well known that Crohn's disease is named after the first 
of three co-authors whose names were arranged alphabetically 
at the head of their clinical and pathological study of 
regional ileitis which appeared in 1932 (1). It is equally 
well known to gastroenterologists and medical historians that 
this important paper was not the first description of this 
condition. 
Historians have traced descriptions of diseases presenting 
with rectal bleeding and weight loss back to the ancient 
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Greeks. Although these may have been cases of dysentery, 
Crohn's disease could explain these findings (2). 
In 1769, Morgagni performed a post mortem on a 34 year old man 
who had died of intestinal perforation and peritonitis. He 
found the terminal ileum and colon to be inflamed, ulcerated 
and strictured, with large mesenteric lymph nodes. Although 
this illness was attributed to intestinal tuberculosis, 
Crohn's disease remains a strong diagnostic candidate (3). 
In 1813, a report of thickening and stricture of the terminal 
portion of the ileum was given before the Royal College of 
Physicians at London by Combe and Saunders : the ileum was 
"contracted for the space of three feet to the size of a 
turkey quill" (3). 
Sir Kennedy Dalziel, in 1913, described 9 patients with 
chronic interstitial enteritis. Dalziel's description is still 
an accurate exposition of the features of the syndrome: "The 
affected bowel gives the consistence and smoothness of an eel 
in a state of rigor mortis, and the glands though enlarged are 
evidently not caseous". 
When considering prognosis and treatment, Dalziel states "As 
far as I am aware, the prognosis is bad except in cases where 
the disease is localised, and even then seems rather hopeless 
unless operation be had recourse to ".(4) 
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The modern history of granulomatous disease of the intestinal 
tract begins with the classic paper by Crohn, Ginzburg and 
Oppenheimer on their 14 cases of regional ileitis (1). In 
their paper they stressed that there are no diagnostic 
microscopic features of this disease. The presence of giant 
cells and granulomas, in their opinion, was an accidental 
finding due to the inclusion of small particles of vegetable 
matter that had become entrapped in the ulcers, entered 
lymphatics and elicited a foreign body reaction. 
Since this original description it took some thirty years 
before criteria of colonic involvement by Crohn's disease were 
described (5). Thus, it was recognised that this syndrome 
could affect the whole gastrointestinal tract and increasing 
numbers of reports of Crohn's disease appeared in the 
literature. 
Initially, the diagnosis of Crohn's disease was made on the 
basis of clinical features and an absence of tuberculosis and 
other infectious conditions. However, as more cases were 
recognised, so pathological criteria were added to the 
definition (6). As alluded to earlier, the pathological 
findings are often non-specific and so endoscopic and 
radiological techniques have added new criteria for the 
diagnosis (7). 
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The aetiology and pathogenesis of Crohn's disease continues to 
baffle researchers to this day. Early workers were convinced 
that the aetiological agent was carried within the faecal 
stream (8). A later hypothesis suggested that Crohn's disease 
arose from the inability of the macrophage to degrade a 
variety of normal gut luminal constituents (9). 
However, it appears that the pathogenesis revolves around a 
complex interplay between genetic and environmental factors, 
although both are poorly understood. A genetic predisposition 
for Crohn's disease was suggested in studies from Sweden (10). 
and Biemond et al (11) showed a relative risk of 1.25 for 
Crohn's disease in people with HLA-A2 antigens. 
There is still no unified concept of aetiology and 
pathogenesis, although recent microbiological studies have 
stimulated interest in an infective aetiology (12). Most 
authors consider dietary factors to be important and an excess 
of smokers has been reported among patients with Crohn's 
disease (13). 
Immunological mechanisms and auto-immunity have been 
considered in the pathogenesis and numerous autoantibodies 
have been detected in the serum of Crohn's disease patients. 
These, however, are thought to represent epiphenomena. 
The demonstration of human mucosal antigens specifically 
recognised by antibodies in the serum of patients with Crohn's 
disease and activity of both serum and circulating lymphocytes 
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against epithelial antigens in mouse intestine is more direct 
evidence for an element of autosensitisation (14). The 
possibility that Crohn's disease represents a diffuse disorder 
affecting the whole of the gastrointestinal tract has been 
suggested by both physiological and immunological studies of 
apparently uninvolved intestine with the disease (15,48). 
Mucosal abnormalities leading to increased permeation of 
antigens across the mucosa have been suggested as mechanisms 
that might potentiate a state of chronic inflammation (15). 
However, these findings have been demonstrated in patients 
with other diseases such as coeliac disease and are therefore 
non-specific (18). 
The pathogenesis of the . extra intestinal manifestations of 
Crohn's disease is equally obscure. Immune complex deposition 
has been postulated as one possible mechanism but the presence 
of immune complexes has not been demonstrated (16). Increased 
circulating concentrations of cytokines, especially 
interleukin I, have been demonstrated in active inflammatory 
bowel disease and are known to be responsible for damage to 
tissues. But, once again these findings are non-specific (16). 
Recently a more controversial mechanism has been postulated to 
explain the features of Crohn's disease. The authors suggest 
that the pathogenesis is related to multifocal 
gastrointestinal infarction and demonstrated occlusive 
fibrinoid lesions of arteries supplying areas of intestine 
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affected by Crohn's disease. It is suggested that the clinical 
and histological features can be explained by this 
pathogenetic mechanism.(17). 
Since its acceptance as a separate entity, the pathology of 
Crohn's disease has been well described in numerous articles 
in the literature (5,6,21,61,65). Macrosc.opically the affected 
bowel has been likened to a hosepipe due to its rigid 
unyielding consistency as a result of marked mural thickening. 
The luminal surface may show a variety of patterns, the 
classical being the so called "cobblestone" appearance. Other 
areas show a more serpiginous type of ulceration often 
combined with areas of stricture. Fissuring ulcers are also 
commonly seen and probably represent the forerunners of the 
fistulae which may develop. 
Another characteristic macroscopic finding is the presence of 
"skip-lesions" with diseased bowel alternating with areas of 
more normal appearing bowel. This discontinuous inflammatory 
process is an important endoscopic clue in the differential 
diagnosis of Crohn's disease. 
Microscopically, the main features include the transmural 
nature of the inflammatory infiltrate with prominent lymphoid 
hyperplasia forming aggregates especially in the deeper 
layers. Oedema and fibrosis of the submucosa are also often 
present with neural hypertrophy a well described feature. The 
mucosa may show considerable variation in the degree and 
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extent of features including inflammatory cell infiltration, 
villous abnormalities, pyloric metaplasia of the crypts of 
Lieberkuhn and ulceration. The presence of epithelioid 
granulomas is still considered to be the microscopic hallmark 
of this disease. However, in the absence of these, the 
diagnosis is fraught with difficulties. 
Early changes in Crohn's disease are important to recognise 
and features described in the small intestine include changes 
in villous morphology (18), goblet cell hyperplasia (8,18) and 
focal necrosis of mucosal epithelium.(19). Aphthous 
ulceration, related to mucosal or submucosal lymphoid 
aggregates, is regarded as one of the more readily 
identifiable early changes in Crohn's disease.(18,20,21) 
However, this feature cannot by itself be regarded as 
diagnostic as it is seen in other inflammatory bowel diseases, 
such as Campylobacter colitis and yersiniosis.(18,22,23) 
Examination of material by electron microscopy has shown 
increased mucous secretion (24) and axonal degeneration. (25) 
The advent of the endoscopic biopsy has allowed the 
histopathologist to study the disease process without reliance 
on resection specimens. By performing colonoscopy the 
physician is able to visualise directly the mucosal surface 
and so obtain an image of the spatial variation of the disease 
process (i.e. right vs. left sided colitis). Geboes and 
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Vantrappen (26) have shown that colonoscopy is superior to 
radiography in defining certain mucosal abnormalities and for 
recognising the segmental distribution of disease. The 
relative ease of procuring these small biopsies allows the 
endoscopist to sample widely from macroscopically normal and 
abnormal mucosa, and to repeat the biopsies in different 
phases of disease activity. This is particularly valuable in 
inflammatory bowel disease as it often takes more than one 
biopsy to distinguish between the different inflammatory 
conditions that can so easily mimic each other clinically. The 
limitations of the mucosal biopsy however, must be appreciated 
and it should be realised that certain helpful features, such 
as depth of mural inflammation or presence of fissures cannot 
be detected (27). Features which favour Crohn's disease 
include granulomas, lymphoid hyperplasia - particularly when 
it extends into the submucosa and causes a disproportionate 
increase between the submucosal and mucosal inflammatory 
infiltrate (28,29,30) - and a patchy infiltrate due to 
variations in extent and degree of chronic inflammatory cells 
in the lamina propria, both within a single biopsy and in 
separate biopsies. Based on counts of inflammatory cells, it 
has been suggested that macrophages in the lamina propria are 
more prominent in Crohn's disease than other inflammatory 
conditions (31). Most other findings, such as crypt abscesses, 
pseudopolyps, submucosal oedema, tissue eosinophils, Paneth 
cell metaplasia and endocrine cell hyperplasia are non-
discriminatory (32,33). Isolated giant cells without definite 
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granulomas are occasionaly present and may simply reflect 
reactions to luminal contents after loss of mucosal integrity 
( 1, 39). 
The finding of granulomas in both biopsy and resection 
specimens, in the absence of other apparent causes is very 
suggestive of Crohn's disease. The incidence of granulomas in 
Crohn's disease however, varies considerably depending on the 
stage of the disease (34), the anatomical location within the 
gastrointestinal tract, the diligence with which the 
histopathologist searches for granulomas (35,36) and whether 
the patient was receiving medical treatment (prednisone and/or 
sulphasalazine) (37). Realising this, different authors have 
reported varying figures as to the incidence of granulomas in 
resection specimens and in mucosal biopsies. Price and Morson 
state that non-caseating sarcoid - like granulomas are found 
in up to 60 per cent of cases of surgical resections (38). 
Goldman and Antonioli emphasize that granulomas are detected 
in only about 50 per cent of cases of Crohn's disease when 
surgically resected bowel wall is available for examination 
( 39). 
The incidence in colonic and rectal mucosal biopsy specimens 
is more limited. In patients with disease limited to the small 
bowel, colonoscopic biospy of the uninvolved colonic mucosa 
reveals granulomas in 5 - 10 per cent of cases, whilst with 
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gross colonic involvement, granulomas are present in up to 25 
per cent of cases (39). 
Schmitz - Moormann et al. found that studying only one biopsy, 
a granuloma was found in 11 per cent of endoscopic biopsies, 
while the study of 6 biopsies increased the incidence of 
granulomas to 47 per cent (40). In the same way, the 
percentage positivity grew with the number of endoscopies -
from 23 per cent for one endoscopy to 48 per cent for four 
endoscopies. From their results, they postulated that 
granulomas always occur in Crohn's disease, but only 
temporarily and not in all intestinal regions. 
The value of rectal biopsies in the diagnosis of Crohn's 
disease has also been widely documented (27 - 30,41 -
47,64,66,67). The probability of finding granulomas in rectal 
biopsies varies from 20 per cent (28, 51) to 39 per cent (42). 
In one series, Lockhart-Mummery and Morson found granulomas in 
16 out of 19 patients who had rectal biopsies (61). The 
considerable variation in incidence presumably relates to 
differences in the number of biopsies examined from each 
patient and in the number of histologic sections examined. In 
order to extract the maximum benefit from a rectal biopsy, 
studies have been done to determine the usefulness of serial 
sectioning. Surawicz et al recommend a partial serial 
sectioning of at least two rectal biopsies with at least 90 
sections (36). Petri et al emphasize that only total serial 
sectioning will ensure that granulomas are not overlooked and 
in their series they examined an average of 623 sections from 
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each biopsy (49). In spite of this they still only encountered 
granulomas in 28 per cent of their cases. 
The variation of granulomas from region to region within the 
bowel has also been studied. In the small bowel there appears 
to be a low incidence, which increases in the colon and 
rectum, with the highest incidence being found in the anus 
(50). The explanation for this is not clear. Theories 
suggested include that it may be due to environmental 
differences - there may be increasing concentrations of 
granuloma-forming material distally. However, the regional 
variation in granuloma incidence would be more likely to 
correlate with the distribution of intestinal involvement 
which does not occur. Another explanation could be that 
different areas of the bowel exhibit inherent differences in 
their ability to respond to the causative agent. 
Other authors have indicated that the number of granulomas 
decreases with long standing illness (40,50) and that ileal 
Crohn's disease presents clinically much later in the disease 
course than more distal disease. 
None of these explanations appears to be entirely 
satisfactory. 
The clinical course of Crohn's disease is punctuated by a 
cyclical waxing and waning of disease activity. There appears 
to be a relentless progression of the disease to the extent 
that the vast majority of patients will eventually require 
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surgical intervention (53,54). In a study from Cape Town it 
was shown that 46 per cent of Crohn's patients come to 
resection within 5 years and 23 per cent have a second 
resection within 5 years of the first resection (57). Because 
of the variability in the clinical course of Crohn's disease, 
numerous attempts have been made to define criteria which 
might predict the likelihood of disease progression in Crohn's 
patients. Initially, clinical indices were defined and 
correlated by the American National Co-operative Crohn's 
Disease (NCCD) Study Group (58). However, these did not appear 
to have any significant predictive value, possibly because the 
parameters included were mainly subjective ones. (eg. 
diarrhoea, abdominal pain and well-being). More objective 
criteria, such as laboratory data as well as radiological and 
colonoscopic features were then analysed as to possible 
predictive value. 
Of more interest to the pathologist is the role of 
histological features in the prediction of Crohn's disease 
activity. Initially it was thought that histological features 
did not relate to clinical course (52). However, as the 
granuloma is considered to be of prime importance in the 
diagnosis of Crohn's disease (in the right clinical setting 
and after exclusion of other causes of granulomatous 
inflammation) it was inevitable that this feature became the 
focus of possible correlation with prognosis. Early studies 
did not demonstrate any differences in prognosis associated 
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with granulomas (8,42,52,54,55). However, in a series reported 
by Glass and Baker (56), the authors found that the presence 
of sarcoid-like granulomata inferred a better prognosis for 
the patient than those without granulomata. These findings 
were subsequently confirmed in a study from St. Marks Hospital 
and the presence of granulomas was considered to be analagous 
to tuberculoid leprosy, in which granuloma formation is 
associated with a higher degree of cell mediated immunity and 
a better clinical outlook (50). 
The fact therefore remains that, at the present time, Crohn's 
disease is still an enigma. The aetiology and pathogenesis are 
obscure, the clinical findings and progression of the disease 
are unpredictable and the histological findings are often non-
specific. With this in mind, this dissertation attempts to 
define and document the incidence of certain histological 
features at presentation in a population of Crohn's disease 
patients from Groote Schuur Hospital. 
The main aim is to determine the incidence of granulomas in 
the study group as a whole, as well as to establish the 
distribution of granulomas within the bowel. A correlation 
between the presence of granulomas and the clinical activity 
of the disease (as assessed by the Crohn's Disease Activity 
Index) is also .sought. 
The incidence of other less specific microscopic changes is 
analyzed and the value of endoscopic and rectal biopsies in 
the diagnosis of Crohn's disease is discussed. 
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CHAPTER2 
MATERIALS AND METHODS 
The records of 148 patients with known Crohn's disease were 
accessed from the data bank of the Crohn's Disease Clinic at 
Groote Schuur Hospital. The original presenting pathological 
specimen from each patient was then retrieved from the files 
of the Department of Anatomical Pathology, University of Cape 
Town. Second and subsequent specimens were not included in 
this study, eliminating therapeutic variables. 
Each specimen had been formalin fixed, paraffin wax embedded 
and stained with haematoxylin and eosin according to standard 
histological procedures. The specimens were then divided into 
3 categories 
(a) resection specimens (42 cases) 
(b) colonoscopic biopsies - including rectal biopsies taken 
at the same time (45 cases) 
(c) isolated rectal biopsies (61 cases) 
Clinical data recorded for each patient included a Crohn's 
Disease Activity Index (CDAI) which coincided with the date 
that the pathological specimen was obtained. The CDAI was 
devised in conjunction with the American National Cooperative 
Crohn's Disease (NCCD) Study Group (58). This index 
quantitates a number of clinical symptoms and signs over a 7 
day period. These variables include the general well-being of 
the patient (assessed by the attending physician), the extent 
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of abdominal pain, the number of soft/liquid stools, the 
presence of an abdominal mass, extra-intestinal manifestations 
and the amount of treatment required to control symptoms. Also 
included are more objective criteria such as the patient's 
body weight and the haematocrit. This clinical index has been 
used for a number of years at the Crohn's disease clinic at 
Groote Schuur Hospital and is an assessment of clinical 
"activity" at that time. 
Index values of 150 and below are associated with quiescent 
disease; values above that indicate active disease and values 
above 450 are seen with extremely severe disease (58). 
The histological parameters that were noted included: 
[Al GRANULOMAS: (in all 148 cases) 
Epithelioid granulomas : large sarcoidal-like accumulations of 
epithelioid macrophages without caseation necrosis 
(Figure 1). In some cases the granulomas had a more 
feathery, loose appearance, related to early 
paralymphatic formation, but these were still 
counted as epithelioid granulomas (Figure 2). 
Microgranulomas : a small ill-defined collection of 
epithelioid macrophages usually measuring 125 to 
200µm in diameter (Figure 3). They do not contain 
giant cells (43). 
Isolated giant cells : a single giant cell without associated 
epithelioid cells. 
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(Bl OTHER INFLAMMATORY CHANGES: (in 45 colonoscopic and 61 
rectal biopsies) 
Ulceration: loss of the surface mucosa with an underlying 
infiltrate of neutrophils. 
Aphthous ulceration: an erosive lesion often related to a 
mucosal or submucosal lymphoid aggregate. There is 
an acute inflammatory exudate associated with the 
lymphoid aggregate (18) (Figure 4). 
Lymphoid hyperplasia: an increase in collections of lymphoid 
cells resembling follicles, often at the base of a 
crypt. 
Mucin depletion: an obvious decrease in the amount of mucin 
within goblet cells . 
Cryptitis : an infiltrate of neutrophils within the crypt 
epithelium (Figure SA). 
Crypt abscess : extension of the neutrophils from the lamina 
propria through the crypt epithelium into the crypt 
lumen (Figure SB). 
Crypt distortion: disturbance of the normal straight tubular 
crypt architecture including crypt atrophy and crypt 
degeneration (Figure SB). 
Non-specific inflammation: more than a few neutrophils was 
considered indicative of "active" inflammation. 
Eosinophils are normally scanty in the large 
intestinal lamina propria and any more than the 
occasional one was considered pathological (23). 
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Plasma cells are normal constituents of the lamina 
propria and their presence was only considered to be 
pathological when two or more were found to be 
"touching". 
The specimens containing non-specific inflammation were 
further categorised according to whether the infiltrate was 
superficial (affecting the upper half of the mucosa only), 
diffuse (a uniformly dense infiltrate) or patchy (a variation 
in density of the inflammatory cells between groups of crypts 
or between one crypt and the next. This is the histological 
counterpart of the gross "skip lesion"). 
Disproportionate submucosal inflammation: this refers to an 
excessive mixed infiltrate within the submucosa 
(Figure 6). This sign is only of value when the 
biopsy is from intact mucosa for, when ulceration is 
present the adjacent superficial submucosa may 
become involved. Disproportionate inflammation 
reflects the transmural nature of the inflammatory 
process. 




[i] Incidence of granulomas: 
The overall incidence of granulomas as well as the incidence 
of epithelioid and microgranulomas in all 148 cases. 
(ii] Distribution of granulomas in the layers of the bowel 
wall: 
In the resection specimens, the presence of granulomas was 
noted according to their distribution within the bowel wall 
i.e. whether they were situated in the mucosa, the superficial 
or deep submucosa, muscularis propria or serosa. 
[iii] Longitudinal distribution of granulomas in the large 
intestine: 
The colonoscopic biopsies were divided into the longitudinal 
site from where they were taken i.e. caecum, ascending colon, 
transverse colon, descending colon, sigmoid and rectum. The 
presence of granulomas was entered accordingly. 
[iv] Intramucosal distribution of granulomas: 
For the colonoscopic and rectal biopsies, the granulomas were 
also recorded as to whether they occurred alone in the lamina 
propria or whether they were associated with a crypt, an ulcer 
or a lymphoid follicle. 
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[v] Correlation with Crohn's Disease Activity Index (CDAI): 
All 148 cases could be divided into whether disease activity 
was present (CDAI > 150) or absent (CDAI < 150). For each 
separate group the presence or absence of granulomas had been 
recorded. Statistical significance was determined by creating 
a 2x2 table and comparing the percentage differences by using 
the chi-square test and from this deriving a p-value. 
A p-value of less than 0.05 is statistically significant (68). 
[II] COLONOSCOPY SPECIMENS: 
[i) Granulomas: 
The incidence of granulomas in colonoscopy specimens was 
compared with other series reported in the literature. 
[ii] Inflammatory changes: 
The incidence of other less specific inflammatory changes and 
the longitudinal distribution of these changes in the large 
intestine was noted i.e. a comparison of right vs left sided 
colonic involvement. 
[iii] Diagnostic value of colonoscopic biopsi~s: 
The number of cases in which inflammatory changes, other than 
granulomas, were specific enough to be confident in proposing 
a diagnosis of Crohn's disease. 
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[iv] Correlation of inflammatory changes with the CDAI: 
A statistical analysis to determine whether signs of 
histological activity, as evidenced by ulceration, neutrophils 
in the lamina propria, cryptitis or crypt abscesses, has any 
correlation with clinical "activity", as assessed by the CDAI. 
(III] RECTAL BIOPSIES: 
[i] Granulomas: 
The incidence of granulomas in rectal biopsies was established 
according to the anatomical location of the disease process. 
The cases were divided as to whether there was macroscopic 
involvement of the rectum or not. Those without rectal disease 
were separated into ileitis only, ileo-colitis or colitis 
only. 
[ii] Inflammatory changes: 
The incidence of less specific inflammatory changes in rectal 
biopsies was recorded. The findings were also tabulated 
according to the anatomical location of the disease process. 
[iii] Diagnostic value of rectal biopsy: 
An attempt was made to evaluate the role of the rectal biopsy 
in the diagnosis of Crohn's disease 
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[iv) Correlation of inflammatory changes with the CDAI: 
As with colonoscopic biopsies, to compare the features of 
histologic activity with the assessment of clinical activity. 
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Figure 1: Epithelioid Granuloma, sarcoid-like. 
Figure 2: Epithelioid Granuloma - loose appearance. 
Figure 3: Microgranuloma - small ill-defined collection of 
epithelioid macrophages. 
Figure 4: Early Aphthous Ulceration. 
Figure 5: A. Cryptitis - Neutrophils in crypt epithelium. 
Figure 5: B. Crypt Abscess 
Crypt Distortion. 




INCIDENCE OF GRANULOMAB IN GBH SERIES 
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FIGURE 7: 
Figure 7: The overall incidence of granulomas. in ~11 specimens 
was 52 per cent. This compares favourably with figures quoted 
in standard pathology textboooks (18,38). 
The graph in figure 7 shows a decreasing incidence of 
granulomas from resection specimens down to rectal biopsies. 
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As the majority of resection specimens were from the small 
intestine, this would seem to imply that there is a decreasing 
incidence of granulomas from the small intestine through the 
colon to the rectum. However, the high incidence in the small 
intestine is most likely due to the amount of material 
available in resection specimens for histological examination 
and not due to a true increase in incidence. This creates a 
false impression of the variation in longitudinal distribution 
of granulomas in the intestine. This topic is illustrated more 
thoroughly further on in the discussion (see figure 11). 
The high incidence of microgranulomas in colonoscopic biopsies 
is a feature which has not been reported before. 
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FIGURE 8: 
INCIDENCE OF GRANULOMAS REPORTED IN 
THE LITERATURE IN RESECTION SPECIMENS 
- " GRANULOMAS I 
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4: Jones-Williams 
5: Wolfson, et al 
6: Cook, Dixon 
7: Hadfield 
8: Glass, Baker 
9: McGovern, Goulston 
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Figure 8: The pathological specimens reported in most of these 
series consisted of both initial and recurrent specimens. In 
series 1,9 and 10 - Gump, et al (54), McGovern and Goulston 
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(53) and Lockhart-Mummery and Morson (61) - initial presenting 
specimens only were examined. 
FIGURE 9: 
DISTRIBUTION OF GRANULOMAS IN THE 
BOWEL WALL OF 42 RESECTION SPECIMENS 
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LAYER IN THE BOWEL WALL 
(IGC = isolated giant cells; SUP SUB= superficial submucosa; 
DEEP SUB= deep submucosa; MUSC PROP= muscularis propria) 
Figure 9: The incidence of granulomas appears to increase from 
I 
the mucosal surface through the superficial and deep submucosa 
to the serosa. A noticeable dip, however, occurs in the 
muscularis propria. This could be due to a difference in 
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lymphatic drainage in the muscularis propria, as granulomas 
have been linked to lymphatic channels (8). The presence of 
lymphoid follicles in the external muscular layer varies from 
15.7 per cent in Van Patter et al's series to 71 per cent in 
the series of McGovern and Goulston (8,53). 
An original finding is the distribution of microgranulomas -
which were only found in .the mucosa and no other layers of the 
intestinal wall. This has . not been reported in the literature 
before. 




COMPARISON OF BOWEL W\.LL DISTRIBUTION 
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Figure 10: The pattern of distribution of granulomas in our 
series is very similar to Van Patter et al.(8). Their series 
consisted of 315 initial presenting resection specimens and 62 
recurrences. The most obvious difference is in the incidence 
of granulomas in the mucosal layer - 15% compared with 4%. The 
presence of microgranulomas (which they did not evaluate) in 
the mucosal layer in 10% of our resection spe~imens would 
account for this. 
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FIGURE 11: 
LONGITUDINAL DISTRIBUTION OF GRANULOMAS 
IN 46 COLONOSCOPIC BIOPSIES 
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Figure 11: This graph shows an apparent increase in incidence 
of granulomas on the left side of the colon with the highest 
numbers in the sigmoid and descending colon. There is an 
appreciable dip in the transverse colon, a finding which is 
supported by Schmitz-Moormann et al (40). They differed 
however in recording a high incidence in the caecum which we 
did not concur with. The low percentage on th~ right side is 
noteworthy as Crohn's disease is supposed to be mainly a 
right-sided disease. Other less specific inflammatory changes 
were found to be increased on the right as would be expected. 
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Figure 12: By far the majority of granulomas in mucosal 
biopsies were situated in the lamina propria and not 
associated with crypts. There is also a trend for 
microgranulomas and epithelioid granulomas to follow each 
other and this would seem to indicate that they are related, 
in the mucosa at least, as has been suggested by others (43). 
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TABLE 1: 
PRESENCE OF GRANULOMAS vs NCCD CLINICAL DISEASE ACTIVITY 
INDEX: ( CDAI ) 




(SCORE <=150) (SCORE >150) 
CASES WITH 
EPITH. GRANS 33 21 54 
CASES WITHOUT 
EPITH. GRANS 43 51 94 
TOTAL CASES 76 72 148 
CHI-SQUARE= 3.86 
p-VALUE < 0.15 
The mean CDAI score for those patients with and without 




EPITH. GRAN POSITIVE 142.25* 
* - p-VALUE < 0.08 
EPITH. GRAN NEGATIVE 172.48* . 
* - the difference between these 2 scores approaches 
statistical significance. 
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p-VALUE < 0.18 
MICROGRAN NEGATIVE 159.61 
The above Tables show that there is no statistical correlation 
between the presence of granulomas (both epithelioid and 
microgranulomas) and clinical disease "activity" (CDAI). 
However, the mean CDAI score is much lower for patients with 
epithelioid granulomas than those without. This difference 
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approaches statistical significance and implies that those 
patients with epithelioid granulomas have less active disease. 
This does not hold true for patients with microgranulomas. 
(II] COLONOSCOPY SPECIMENS: 
II (i) GRANULOMAS: 
FIGURE 13: 
COMPARISON OF THE INCIDENCE OF 
GRANULOMAS IN COLONOSCOPIC BIOPSIES 















Figure 13: REFERENCES: 
G•ba•• Schmitz.- Fruhmarg•n Mauwlu•n 
Mciarrnann 
241, 401, 331, 
Geboes et al (26) 
Schmitz-Moormann et al (40) 
Fruhmorgen (69) 
Meuwissen et al (70) 
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In our series, we separated the total granulomas into 
epithelioid granulomas and microgranulomas. Schmitz-Moormann 
et al are the only other series reported with microgranulomas 
although they did not separate them from epithelioid 
granulomas (40). Their total incidence was 56% - which 
compares favourably with our figure of 53%. 
Geboes et al found epithelioid granulomas in 24% of 
colonoscopic biopsies (26). This differs slightly to 
Fruhmorgen and Meuwissen et al who obtained figures of 40% and 
33% respectively (69,70). 
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II (ii) INFLAMMATORY CHANGES: 
FIGURE 14: 
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Figure 14: Only 16% of colonoscopic biopsies were considered 
to be normal histologically. This compares favourably with 
Schmitz-Moormann et al (40) who found no inflammation in 12% 
of their biopsies. A patchy inflammatory infiltrate, a feature 
which is very suggestive of Crohn's disease, was found in 57% 
of cases. 
Inflammatory changes tend to be found more often on the right 
side than on the left - 66% vs 51% - although the difference 
between these figures is not statistically significant (p < 
0.24). This is in keeping with the fact that Crohn's disease 
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is considered to affect the right side predominantly - but is 
in contrast to the incidence of granulomas which was found to 
be higher on the left side (see Figure 11). 
FIGURE 15: 
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Figure 15: A large number of cases (53%) showed histologic 
evidence of ulceration, with aphthous ulceration, which is a 
feature often associated with Crohn's disease, in 18%. Of note 
was that crypt abscesses were found in 42% of cases, whilst 
distortion of crypt architecture was present in 13% - implying 
that 87% of cases maintained a normal architectural pattern. 
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TABLE 2: 
II (ii) : INFLAMMATORY CHANGES IN COLONOSCOPIC BIOPSIES: 
TOTAL RIGHT TRANSVERSE LEFT 
COLON COLON COLON 
(45) (32) (20) (35) 
ULCERATION 53% 44% 2% 31% 
APHTHOUS ULCERATION 18% 9% 0 17% 
LYMPHOID HYPERPLASIA 31% 28% 2% 14% 
MUCIN DEPLETION 24% 22% 2% 17% 
CRYPTITIS 27% 31% 7% 6% 
CRYPT ABSCESS 42% 22% 9% 34% 
CRYPT DISTORTION 13% 9% 0 11% 
EXCESS PLASMA CELLS 84% 88% 31% 74% 
EXCESS EOSINOPHILS 82% 75% 29% 71% 
DISPROPORTIONATE 
SUBMUC INFLAMMATION 11% 4% 0 7% 
A noticeable decrease in inflammatory changes in the 
transverse colon is present, which tends to follow the low 
incidence of granulomas in this region (see Figure 11). These 
figures might not be representative, however, due to the small 
number of specimens in this group. 
There is a higher incidence of aphthous ulceration in biopsies 
from the left colon than from the right - 17% vs 9% - although 
this difference is not statistically significant (p < 0.35). 
Most of the other histological parameters are more prevalent 
on the right side. 
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TABLE 3: 
[II] (iii): DIAGNOSTIC VALUE OF COLONOSCOPIC BIOPSIES: 
TOTAL CASES= 45 
APHTHOUS 
ULCERATION 8 (18%) 
DISPROP SUBMUCOSAL 
INFLAMMATION 5 (11%) 
PATCHY INFLAMMATION 
+ 
NORMAL ARCHITECTURE 18 (40%) 
DIAGNOSTIC 24 (53%) 
In the right clinical setting, other histological lesions 
which are characteristic of Crohn's disease include the 
presence of aphthous ulceration, disproportionate submucosal 
inflammation and a patchy inflammatory infiltrate in a biopsy 
with normal crypt architecture (20,28,29,30,39,60). 
These features were found in 18%, 11% and 40% of cases 
respectively. Taking into account that some of the lesions 
occurred together in the same biopsy, features characteristic 
of Crohn's disease were found in a total of 24 cases - . 53%. 
Thus, in just over half the biopsies, a histologic diagnosis 
of Crohn's disease could be confidently proposed, even in the 
absence of granulomas. 
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TABLE 4: 
III (iv) : CORRELATION BETWEEN INFLAMMATORY CHANGES IN 
COLONOSCOPIC BIOPSIES AND THE CLINICAL DISEASE ACTIVITY INDEX 
(CDAI): 
a) ULCERATION: 
NCCD ACTIVITY INDEX SCORE 
p -VALUE< 0.11 
QUIESCENT ACTIVE 
DISEASE DISEASE 
(SCORE<= 150) (SCORE >150) 
ULCERATION PRESENT 16 8 24 
ULCERATION ABSENT 9 12 21 
TOTAL CASES 25 20 45 
No statistical correlation between the presence or absence of 
histological ulceration and clinical disease activity - (p < 
0.11). 
b) APHTHOUS ULCERATION: 
NCCD ACTIVITY INDEX SCORE 
p -VALUE< 0 48 
QUIESCENT ACTIVE 
DISEASE DISEASE 
(SCORE<= 150) (SCORE >150) 
APHTHOUS ULCERATION 
PRESENT 5 3 8 
APHTHOUS ULCERATION 
ABSENT 20 17 37 
TOTAL CASES 25 20 45 
No statistical correlation between presence or absence of 
aphthous ulceration and clinical disease activity (p < 0.48) 
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c) MUCIN DEPLETION: 
NCCD ACTIVITY INDEX SCORE 
p -VALUE< 0.60 
QUIESCENT ACTIVE 
DISEASE DISEASE 
(SCORE<= 150) (SCORE >150) 
MUCIN DEPLETION 
PRESENT 6 5 
MUCIN RETENTION 19 15 
TOTAL CASES 25 20 
No statistical correlation between mucin depletion and 
clinical disease activity (P < 0.60). 
d) NEUTROPHILS IN THE LAMINA PROPRIA: 
NCCD ACTIVITY INDEX SCORE 
p -VALUE< 0.43 
QUIESCENT ACTIVE 
DISEASE DISEASE 
(SCORE <= 150) (SCORE >150) 
NEUTROPHILS PRESENT 9 5 
NEUTROPHILS ABSENT 16 15 







No statistical correlation between the presence of neutrophils 
in the lamina propria (i.e. histological evidenc~ of activity) 
and clinical disease activity (P < 0.43). 
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e) CRYPTITIS: 
NCCD ACTIVITY INDEX SCORE 
p -VALUE< 0.82 
QUIESCENT ACTIVE 
DISEASE DISEASE 
(SCORE <= 150 (SCORE >150) 
CRYPTITIS PRESENT 7 5 12 
CRYPTITIS ABSENT 18 15 33 
TOTAL CASES 25 20 45 
No statistical correlation between cryptitis and clinical 
disease activity (p < 0.82). 
f) CRYPT ABSCESSES: 
NCCD ACTIVITY INDEX SCORE 
p-VALUE < 0.79 
QUIESCENT ACTIVE 
DISEASE DISEASE 
(SCORE<= 150) (SCORE >150) 
CRYPT ABSCESS 
PRESENT 11 8 
CRYPT ABSCESS 
ABSENT 14 12 
TOTAL CASES 25 20 
No statistical correlation between crypt abscesse·s and 





[III] RECTAL BIOPSIES: 
TABLE 5: 
III (i) : PRESENCE OF GRANULOMAS IN RECTAL BIOPSIES CORRELATED 
WITH ANATOMICAL DISTRIBUTION OF DISEASE~ 
DISTRIBUTION OF DISEASE INVOLVEMENT 




ILEITIS !LEO-COLITIS COLITIS 
( 19) ( 19) ( 12) ( 11) 
R L T R L T 
( 9 ) ( 1 ) ( 9 ) ( 0 ) ( 1 ) (11 
EPITH GRAN 2 1 .1 4 0 0 4 4 
MICROGRAN 0 0 0 0 0 1 4 2 
TOTAL 2 6 7 5 
(11%) (32%) (58%) (45%) 
R = right colonic involvement; L = left colonic involvement; T 
= total colon involved. 
Those cases with a macroscopically normal appearing rectum 
were then divided according to the distribution of disease 
involvement into ileitis only, ilea-colitis and colitis only. 
The incidence of granulomas in a biopsy of normal rectum 
increases from 11% in patients with ileal involvement only to 
58% in patients with colonic disease. 
Granulomas are also more often found when there is total 
colonic involvement as opposed to right or left sided disease. 
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When the rectum is involved by the disease process, granulomas 
are present in 45% of cases. 
The number of cases in each group is relatively small and this 
detracts from the significance of the results. 
Microgranulomas are found mainly in left sided disease and as 
these are early lesions, these patients presumably present 




III (ii) INFLAMMATORY CHANGES IN RECTAL BIOPSIES: 













Figure 16: Of the 61 rectal biopsies 39% were considered to be 
normal. Inflammatory changes were present in 50%. 
11% of biopsies showed no significant inflammatory infiltrate, 
but were not considered normal as they demonstrated other 




INFLAMMATORY CHANGES PRESENT IN 61 ISOLATED RECTAL BIOPSIES: 
% OF ALL % OF ABNORMAL 
NO.OF CASES RECTAL BIOPSIES RECTAL BIOPSIES 
( 61) ( 3 7) 
INFLAMM sup 7 11% 19% 
patchy 16 26% 43% 
diffuse 8 13% 21% 
TOTAL 31 50% 83% 
APHTHOUS ULCER 8 13% 21% 
DISPROP. SUBMUC 3 5% 8% 
INFLAMMATION 
LYMPH HYPER 8 13% 21% 
CRYPTITIS 7 11% 19% 
CRYPT ABSCESS 8 13% 21% 
CRYPT DISTORTN 4 7% 11% 
MUCIN DEPLETION 2 3% 5% 
Of the 61 rectal biopsies, 50% showed inflammatory changes. A 
patchy inflammatory infiltrate was seen in 26%. 
Aphthous ulceration was present in 13% and disproportionate 
submucosal inflammation in 5%. 
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TABLE 7: 
INFLAMMATORY CHANGES IN RECTAL BIOPSIES CORRELATED WITH 
ANATOMICAL DISTRIBUTION OF DISEASE: 
DISTRIBUTION OF DISEASE INVOLVEMENT 




ILEITIS !LEO-COLITIS COLITIS 
( 19) ( 19) ( 12) ( 1 1 ) 
INFLAMM. sup 1(5%) 3(16%) 2(17%) 1(9%) 
patchy 5(26%) 4(21%) 6(50%) 1(9%) 
diffuse 0 2(11%) 2(17%) 4(36%) 
TOTAL 6(31%) 9(47%) 10(83%) 6(55%) 
APHTHOUS ULCER 0 2(11%) 4(33%) 2(18%) 
DISPROP. SUBMUC 1(5%) 2(11%) 0 0 
INFLAMMATION 
LYMPH HYPERPLASIA 2(10%) 3(16%) 1(8%) 4(36%) 
CRYPTITIS 1(5%) 1(5%) 4(33%) 2(18%) 
CRYPT ABSCESS 1(5%) 2(11%) 4(33%) 2(18%) 
CRYPT DISTORTION 1(5%) 0 3(25%) 1(9%) 
MUCIN DEPLETION 0 0 1(8%) 1(9%) 
Even in macroscopically normal rectal mucosa, inflammatory 
changes were found in a significant number of biopsies. The 
incidence tended to increase from 31% in patients with disease 
confined to the ileum to 83% in those with colitis. 
Aphthous ulceration was found significantly more often in 
patients with colonic involvement than those with more 
proximal disease (p < 0.04). 
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In patients with clinical involvement of the rectum, 
inflammatory changes were found in 55% of cases only. 
The numbers of cases in each category is small, however, and 
this places some limitation on the value of the figures. 
TABLE 8: 
III (iii) : THE DIAGNOSTIC VALUE OF RECTAL BIOPSY: 
NORMAL 24 (39%) 
ABNORMAL 37 (61%) 
Non-specific 9 (15%) 
Diagnostic 28 (46%) 
Diagnostic, or highly suggestive, biopsies included:-
a) the presence of granulomas 
b) aphthous ulceration 
c) disproportionate submucosal inflammation 
d) a combination of patchy inflammation and normal crypt 
architecture together in the same biopsy. 
Of the 61 rectal biopsies, 24 (39%) were considered to be 
normal. 37 (61%) showed microscopic abnormalities although 
only 11 (18%) were considered to be abnormal macroscopically 
( see Table 7 ) . 
Table 8 above, shows the number of diagnostic cases including 
those with granulomas. 
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Even in the absence of granulomas, certain features strongly 
favour the diagnosis of Crohn's disease. 
TABLE 8A: 
TOTAL NO.OF CASES= 61 
APHTHOUS 
ULCERATION 8 (13%) 
DISPROP. SUBMUCOSAL 
INFLAMMATION 3 ( 5%) 
PATCHY INFLAMMATION 
+ 14 (23%) 
NORMAL ARCHITECTURE 
HIGHLY SUGGESTIVE 25 (41%) 
Thus, even in the absence of granulomas, rectal biopsies were 
still highly suggestive of Crohn's disease in 41% of cases. 
TABLE 8B: 
DIAGNOSTIC FEATURES IN RECTAL BIOPSY vs MACROSCOPIC APPEARANCE 
OF THE RECTUM: 
MACROSCOPIC APPEARANCE 
NORMAL ABNORMAL TOTAL 
(50) ( 11) (61) 
APHTHOUS 
ULCERATION 6 (12%) 2 (18%) 8 (13%) 
DISPROP. SUBMUCOSAL 
INFLAMMATION 3 ( 6%) 0 3 ( 5%) 
PATCHY INFLAMMATION 
+ 13 (26%) 1 ( 9 % ) 14 ( 2 3%) 
NORMAL ARCHITECTURE 
HIGHLY SUGGESTIVE 22 (44%) 3 (27%) 25 (41%) 
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A rectal biopsy from a macroscopically normal rectum showed 
features highly suggestive of Crohn's disease in 44% of 
cases. 
In an involved rectum, a biopsy was highly suggestive in 27% 
of cases. As only 11 biopsies of abnormal rectum were 
performed, there is some limitation on the value of the 
figures obtained. 
TABLE 9: 
III (iv) : CORRELATION BETWEEN INFLAMMATORY CHANGES IN RECTAL 
BIOPSIES AND CROHN'S DISEASE ACTIVITY INDEX (CDAI): 
a) ULCERATION: 
NCCD ACTIVITY INDEX SCORE 
p-VALUE < 0.65 
QUIESCENT ACTIVE 
DISEASE DISEASE 
(SCORE <= 150) (SCORE >150) 
ULCERATION PRESENT 3 4 7 
ULCERATION ABSENT 28 26 54 
TOTAL CASES 31 30 61 
No statistical significance between the presence of histologic 
ulceration and clinical disease activity (p < 0 . 65). 
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b) APHTHOUS ULCERATION: 
NCCD ACTIVITY INDEX SCORE 
p-VALUE < 0.48 
QUIESCENT ACTIVE 
DISEASE DISEASE 
(SCORE<= 150) (SCORE >150) 
APHTHOUS ULCERATION 
PRESENT 5 3 8 
APHTHOUS ULCERATION 
ABSENT 26 27 53 
TOTAL CASES 31 30 61 
No statistical significance between aphthous ulceration and 
clinical disease activity (p < 0.48). 
c) MUCIN DEPLETION: 
NCCD ACTIVITY INDEX SCORE 
p-VALUE < 0.98 
QUIESCENT ACTIVE 
DISEASE DISEASE 
(SCORE<= 150) (SCORE >150) 
MUCIN DEPLETION 
PRESENT 4 4 
MUCIN RETENTION 27 26 
TOTAL CASES 31 30 
No statistical correlation between mucin depletion and 





d) NEUTROPHILS IN THE LAMINA PROPRIA: 
NCCD ACTIVITY INDEX SCORE 
p -VALUE< 0.40 
QUIESCENT ACTIVE 
DISEASE DISEASE 
(SCORE <= 150) (SCORE >150) 
NEUTROPHILS PRESENT 4 7 11 
NEUTROPHILS ABSENT 27 23 so 
TOTAL CASES 31 30 61 
No statistical significance between neutrophils in the lamina 
propria (histologic active disease) and clinical disease 
activity (p < 0.40). 
e) CRYPTITIS: 
NCCD ACTIVITY INDEX SCORE 
p -VALUE< 0.65 
QUIESCENT ACTIVE 
DISEASE DISEASE 
(SCORE <= 150) (SCORE >150) 
CRYPTITIS PRESENT 3 4 7 
CRYPTITIS ABSENT 28 26 54 
TOTAL CASES 31 30 61 
No significant correlation between the presence of cryptitis 
and clinical disease activity (P < 0.65). 
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f) CRYPT ABSCESSES: 
NCCD ACTIVITY INDEX SCORE 
p -VALUE< 0.48 
QUIESCENT ACTIVE 
DISEASE DISEASE 
(SCORE<= 150) (SCORE >150) 
CRYPT ABSCESS 
PRESENT 5 3 8 
CRYPT ABSCESS 
ABSENT 26 27 53 
TOTAL CASES 31 30 61 
No statistical correlation between the presence of crypt 





This dissertation is a retrospective study of a cohort of 
known Crohn's disease patients in which, well known 
histological indices from initial presenting pathological 
specimens are analysed. The single most important histological 
finding in the diagnosis of Crohn's disease is the epithelioid 
granuloma . More recently, less obvious granulomatous foci, 
designated microgranulomas have been described (43). This 
lesion is thought to possibly represent a precursor of the 
more mature epithelioid granuloma. 
[i] Incidence of granulomas: 
As the pathological specimens in this series varied from full 
resection specimens to endoscopic biopsies and solitary rectal 
biopsies, it is interesting to compare the incidence of 
granulomas in the different material available (Figure 7). 
Most figures quoted in the literature are obtained from 
analysing resection specimens and vary from 36 per cent of 
cases to 75 per cent (Figure 8). Most of the specimens 
examined included both small and large intestine. None of 
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these series, however, took into account the presence of 
microgranulomas - seen in 27 per cent of our resection 
specimens. By including this feature, the incidence of 
granulomas in resection specimens increased from 68 per cent 
to 76 per cent. 
(ii) Distribution of granulomas in the layers of the 
intestinal wall: 
The distribution of granulomas within the bowel wall shows 
that the highest incidence occurs in the submucosa and that 
the mucosa has the lowest incidence of epithelioid 
granulomas.(Figure 9). A high incidence of granulomas is also 
found in the serosal layer. However there is a noticeable 
decrease in incidence in the muscularis propria. This could be 
due to a reduction in lymphatic drainage and lymphoid 
follicles in the muscular layer and, in our experience and 
that of other authors, granulomas in Crohn's disease are often 
associated with lymphatic vessels (8,65). The lymphatic 
drainage of the muscularis propria has been shown to be 
derived from the submucosal plexus. Lymph vessels run through 
the muscularis externa where they receive tributaries from the 
lymphatic plexus in the muscular coat and then follow the 
blood vessels into the retroperitoneal tissue (71). Van fatter 
et al found lymphoid follicles in the muscularis propria in 
only 15.7% of their cases, whilst McGovern and Goulston found 
them in 71% of cases (8,53). Van Patter et al also felt that 
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granulomas in the muscular layer appeared to develop and 
regress later than those in other layers (8). The large 
discrepancy in the incidence of lymphoid follicles and the 
decrease in granulomas in the muscularis propria are not easy 
to explain fully, but are posibly related to the length of 
time of the disease process. 
Microgranulomas were only found in the mucosa and not in any 
other layers of the bowel wall (Figure 9). This finding has 
not previously been well documented in the literature. The 
microgranuloma is thought to be an early precursor lesion of 
the more mature epithelioid granuloma (43), but as they are 
not found along with mature granulomas in the other layers of 
the intestine, it is possible that in the deeper layers, the 
two are not related. 
Isolated giant cells occurred throughout the bowel wall and 
were often present in conjunction with fissuring ulceration. A 
reasonable assumption then would be that they represent a 
foreign body type of response to ingested material and are a 
non-specific finding.(1,39,62) 
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(iii) Longitudinal distribution of granulomas in the large 
intestine: 
The longitudinal distribution of granulomas in the large 
intestine is another interesting feature. Chambers and Morson 
found a low incidence in the ileum with increasing frequency 
in colon, rectum and anus (50). They postulated that this may 
be due to environmental differences or differences in tissue 
susceptibility. Schmitz-Moormann et al, in a study of colonic 
and rectal biopsies found the highest frequency of granulomas 
in the caecum and descending colon and the lowest values were 
seen in the transverse colon and rectum (40). 
Our figures for colonoscopic biopsies show that within the 
colon granulomas were most often found on the left side of the 
colon - in the sigmoid and descending colon - and least often 
found in caecum and transverse colon (Figure 11). This is at 
slight variance with the general perception that Crohn's 
disease affects mainly the right side of the colon. Other less 
specific inflammatory features were, however, found more often 
on the right side than the left (Figure 14). The 
identification of regressed granulomas is difficult (8), but 
if these were shown to be present in the right side of the 
colon, it could be suggested that the regional variation is 
related to the length of time until presentation. As with 
caecal carcinoma, which classically remains occult longer than 
more distal tumours, right sided Crohn's disease may manifest 
or require surgical intervention at a later stage in the 
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disease cour$e than left sided involvement and that by this 
time granulomas are less obvious histologically (40,50,51). 
(iv) Intramucosal distribution of granulomas: 
In mucosal biopsies, the highest incidence of granulomas 
occurred in the lamina propria (Figure 13). Some authors have 
suggested that granulomas in Crohn's disease are a secondary 
phenomenon and not part of the primary pathological process 
(8), whilst others have alluded to the fact that the initial 
event in the formation of a mucosal granuloma seems to be the 
aggregation of lymphocytes at the base of a crypt. The crypt 
epithelium then disintegrates and ruptures with formation of a 
granuloma around degenerating epithelium (46,53). Our findings 
were that in the mucosa only 13 per cent of granulomas were 
associated with crypts and 35 per cent were isolated in the 
lamina propria, although serial sectioning of the biopsies was 
not performed routinely. This would infer that the formation 
of granulomas does not correspond to disintegration of crypt 
epithelium, but is aligned to some other aetiological process. 
A number of authors have documented the relat~onship of 
granulomas to lymphoid tissue and lymphatics (8,51,65). This 
may be true in the deeper layers of the intestinal wall, but 
it is a well known feature that the mucosal layer does not 
contain lymphatics (72). Also, in our series we did not find 
significant numbers of granulomas associated with lymphoid 
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follicles in the mucosa (Figure 12). Another interesting 
feature seen in Figure 12 is the trend for microgranulomas to 
follow the incidence of epithelioid granulomas. This trend 
does not appear in the other layers of the intestinal wall 
(see Figure 9). 
The interpretation of these findings seems to suggest that 
granulomas in the mucosal layer are somehow different to those 
found in other layers of the intestinal wall - and that in 
this layer, microgranulomas may be found as precursor lesions. 
(v) Correlation of the presence of granulomas with the Crohn's 
Disease Activity Index (CDAI): 
The question of the relationship of granulomas to clinical 
course is a vexing one. In this study, granulomas were 
compared to the NCCD clinical index (58). Previous series have 
used different indices when assessing the relationship of 
granulomas to clinical prognosis. Van Patter et al (8), 
Antonius et al (52), Gump et al (54) and Wolfson et al (55) 
compared the presence of granulomas in resection specimens to 
the recurrence rate. They found no correlation between the 
two. Ward and Webb (42) assessed the usefulness of rectal 
biopsies as an indicator of prognosis in Crohn's 
proctocolitis. Their material included patients with disease 
limited to the colon who had rectal biopsy material available 
for review. The clinical outcome of the patients was assessed 
as being good (asymptomatic), moderate (symptomatic), 
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requiring colectomy and death from disease. They found no 
correlation between the presence of granulomas and clinical 
outcome. However, they found that there was an increase in 
degree of histological abnormality in biopsies of patients who 
subsequently died of granulomatous colitis. They also showed 
that the presence of ulceration and fissures histologically 
correlated with a bad prognosis. 
In 1976, Glass and Baker reported in their series on the role 
of the granuloma in recurrent Crohn's disease that the 
presence of granulomas within a specimen at primary excision 
appeared to offer a better prognosis (56). Again, they 
compared resection specimens against evidence of recurrence 
displayed by either further operation and histological or 
radiological evidence of disease. Symptomatic evidence of 
recurrence alone was not accepted. These findings conflicted 
with the previous reports mentioned. Chambers and Morson 
followed this with a paper representing an attempt to relate a 
quantification of granulomas in bowel resected for Crohn's 
disease with the subsequent course of the disease (50). They 
assessed the subsequent course of the disease by dividing the 
patients into four groups : those with no evidence of 
recurrent disease, those with radiological or biopsy evidence 
in previously uninvolved bowel, those who required surgery and 
those whose symptoms and signs persisted postoperatively for 
more than six months. By quantitating the number of granulomas 
per section examined, they found that the group with no 
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recurrence had significantly more granulomas per section than 
those patients whose disease persisted or recurred after 
surgery. This was in general agreement with the findings of 
Glass and Baker (56). 
A slightly different approach was pursued in this study, in 
that an attempt was made to compare histological lesions with 
the Crohn's Disease Activity Index (CDAI) (58). By using this 
index an assessment of disease activity at the time of biopsy 
was obtained and thus one would expect this to correlate with 
the microscopic findings, irrespective of whether the patient 
was on treatment or not. The statistical analysis (chi-square 
and p-values) showed no correlation between the presence or 
absence of granulomas and the NCCD index (Table 4). However, 
what was of interest was that the mean NCCD score for patients 
with granulomas was 142.25 and the mean score for patients 
without granulomas was 172.48. The difference between these 
figures approaches statistical significance (p < 0.08) and 
this would suggest that patients with granulomas have less 
disease activity and therefore are less likely to relapse. If 
correct, these findings would tend to support the conclusions 
of Chambers and Morson and Glass and Baker (50,56) 
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[II] COLONOSCOPY SPECIMENS: 
(i) Granulomas: 
Colonoscopy has provided increasing amounts of material for 
histological evaluation in patients ·with Crohn's disease. 
Recognising the limitations in interpreting mucosal biopsies, 
the -presence of granulomas is still of major importance (39). 
53 per cent of the colonoscopic biopsies in this series 
contained granulomas. Although this is noticeably higher than 
the incidence quoted in some series in the literature (figure 
13), the latter figures were limited to the presence of 
epithelioid granulomas only and did not take microgranulomas 
into account. Schmitz-Moormann et al, in a similar series 
found both epithelioid and microgranulomas in 56% of cases 
( 40). 
Figure 13 shows that 27 per cent of cases contained 
epithelioid granulomas (which compares favourably with other 
series) and in 42 per cent microgranulomas were present 
(26,69,70). We did not differentiate as to whether the 
biopsies obtained were from macroscopically normal or abnormal 
bowel (26,39). 
These figures show that the presence of microgranulomas is of 
considerable importance and adds significantly to the 
diagnostic criteria for Crohn's disease. 
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(ii) Inflammatory changes: 
Figure 14 indicates that 84 per cent of all colonoscopic 
biopsies in our series were considered to be abnormal and 
there was a higher incidence of abnormalities of the right 
side of the colon compared to the left - 66 per cent versus 51 
per cent. Although this difference is not statistically 
significant (P < 0.24), this is still a well recognised 
feature of Crohn's disease (5). In a similar series, 12 per 
cent of colonic biopsies showed no evidence of inflammation 
(40). The high incidence of abnormalities in colonoscopic 
biopsies could be biased by the endoscopists tendency to 
biopsy macroscopically abnormal areas. However, one of the 
distinguishing features of Crohn's disease is the focality of 
the process and one would expect this to be reflected in the 
histology as well. At the level of the individual biopsy, a 
patchy inflammatory infiltrate was found in 57 per cent of 
colonic biopsies with a diffuse inftltrate in 20 per cent 
(Figure 14). 
Figure 15 shows the incidence of other inflammatory changes 
present. Mucin depletion, or loss of goblet cells and crypt 
architectural distortion - characteristics which are said to 
be more typical of ulcerative colitis than Crohn's disease -
were found in 24 per cent and 13 per cent of colonoscopic 
biopsies respectively. Distortion of ~he crypt architecture 
will, however, be present at the edge of ulcers and so 
endoscopy bias is important in interpreting this result. 
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Of note was the presence in 42 per cent of cases of crypt 
abscesses which have been said to be commoner with ulcerative 
colitis than Crohn's disease. They are of more use as an index 
of histological activity than in differentiating between these 
two inflammatory bowel diseases. 
On examining the inflammatory changes according to their 
anatomical location in the colon, one sees that most of the 
changes are more prevalent on the right side (Table 2). 
One of the noticeable exceptions to this is the presence of 
aphthous ulceration, which is considered to be one of the 
earliest identifiable histological lesions of Crohn's disease 
(18,20). This erosive or ulcerating lesion is often related to 
a mucosal or submucosal lymphoid aggregate and the first stage 
in the development of an ulcer appears to be degeneration of 
the basal cells of the mucosal tubules immediately overlying a 
lymphocytic accumulation which is the area of antigen exchange 
(53). An acute inflammatory exudate develops and extension of 
this process presumably results in the development of fissures 
and fistulae. Early aphthous ulceration was found in 18 per 
cent of colonoscopic biopsies (Figure 15, Table 2) - 17 per 
cent occured on the left side and 9 per cent on the right 
side. These findings would correlate with the assumption that 
the disease process is initiated in the terminal ileum with 
early progression to the right side of the colon (50,65). Left 
sided involvement occurs later in the disease process, often 
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by the time the patient presents clinically and therefore 
early changes are more likely to be present in biopsy 
specimens of this region. This proposition is compatible with 
the explanation given for the longitudinal distribution of 
granulomas, as discussed earlier. 
However, a more simple explanation might be that the results 
are related to the accessibility of the regions of the colon 
to the endoscopist and it is easier to visualise and biopsy 
the left side than the right. 
Another feature of the anatomical distribution of inflammatory 
changes in our series is the generally low incidence of 
abnormalities in the transverse colon. This holds true for 
both granulomas and other inflammatory lesions (Figure 11 and 
Table 2). There appears to be an unexplained sparing effect of 
the transverse colon by the disease process. Schmitz-Moormann 
et al found a similar low incidence of granulomas in the 
transverse colon, but did not find other inflammatory changes 
to be significantly reduced in this region (40). 
(iii) Diagnostic value of colonoscopic biopsies: 
The development of the flexibile fibreoptic -colonoscope has 
increased the amount of material available for the 
histopathologist to examine. Only limited patterns of injury, 
however, can be revealed in biopsy samples (28,39). As 
granulomas are only found in about half of colonoscopic 
63 
biopsies, other less specific inflammatory changes need to be 
closely scrutinized in the diagnosis of Crohn's disease. 
Pathologists in general are very wary about confidently 
diagnosing Crohn's disease in the absence of granulomas and 
are often tempted to interpret a biopsy as only showing "non-
specific inflammation". 
Although many fea~ures have been described in biopsies of 
Crohn's disease, most in isolation do not help in 
distinguishing it from other forms of colitis (20,29,60). 
Apart from the presence of granulomas, findings, which in the 
right clinical setting, strongly favour the diagnosis of 
Crohn's disease include: aphthous ulceration (18,20), 
disproportionate submucosal inflammation 
(20,28,29,30,36,45,53), a focal or patchy inflammatory 
infiltrate with maintenance of the normal crypt architecture 
(30,39,60) and a normal rectal biopsy in a definite case of 
"colitis" (38). 
Table 3 demonstrates that in 24 cases (53%) one or more of 
these features were present. Thus, one would be reasonably 
confident in making a histological - or at least supporting a 
clinico-radiological - diagnosis of Crohn's disease in just 
over half the cases, even in the absence of granulomas. 
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(iv} Correlation of inflammatory changes with the Crohn's 
Disease Activity Index (CDAI}: 
In order to evaluate therapeutic trials in Crohn's disease it 
has been important to assess disease activity in patients. By 
using the NCCD clinical index, we attempted to correlate the 
presence or absence of certain histological findings in 
colonoscopic biopsies with the physician's assessment of 
activity (Table 4). None of the histological features of 
active colitis showed significant correlation with clinical 
evidence of active disease. This significant negative finding 
would imply that the Crohn's Disease Activity Index is a 
relatively inaccurate method of assessing disease severity at 
the tissue level. 
A previous study relating disease activity indices with 
colonoscopic findings obtained similar results (62). 
(III] RECTAL BIOPSIES: 
(i} Granulomas: 
Rectal biopsy is one of the simplest and most. frequently 
performed investigations in the diagnosis of Crohn's disease. 
In the rectal biopsies of this series, granulomas were found 
in a total of 33 per cent of cases, with epithelioid 
granulomas in 26 per cent and microgranulomas in 12 per cent 
(Figure 7). The significance and value of these figures, 
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though becomes more apparent when one analyses the incidence 
of granulomas in conjunction with the extent and distribution 
of bowel involved by the disease process (Table 5). The closer 
the disease process approaches the rectum, the more likely one 
is to find granulomas in a rectal biopsy (28). In those 
patients with disease confined to the ileum alone, biopsy of 
the normal appearing rectum revealed granulomas in 11 per cent 
of cases. 32 per cent of rectal biopsies from patients with 
ilea-colitis and a macroscopically normal rectum and 58 per 
cent of cases with colitis and a normal rectum, contained 
granulomas. 
Biopsy of a macroscopically involved rectum, revealed 
granulomas in 45% of cases 
(ii) Inflammatory changes: 
If one looks at all the rectal biopsies, 24 out of 61 (39 per 
cent) were considered to be normal microscopically and 37 (61 
per cent) showed some abnormality (Figure 16). 
An inflammatory infiltrate was present in 50 percent of 
biopsies with a patchy infiltrate present in 26 per cent. 
Mucin depletion and crypt architectural distortion, which are 
more often associated with ulcerative colitis, were only found 
in a minority of cases whilst crypt abscesses were much less 
common than in the colon (Table 6). 
66 
As with granulomas, inflammatory changes in rectal biopsies 
increase in incidence as the disease process approaches the 
rectum (Table 7). The fact that only 55% of cases with 
macroscopic disease of the rectum showed microscopic 
inflammatory features, confirms again that macroscopic 
findings do not correlate well with changes seen on tissue 
level (62). 
Inflammatory changes are present in a number of rectal 
biopsies even when the disease process is limited to other 
areas of the bowel (Table 7). Non-specific inflammatory 
changes were found in 50 per cent of all rectal biopsies. 
Almost one-third of rectal biopsies in patients with disease 
limited to the ileum, showed inflammatory changes. 47 per cent 
of cases with ilea-colitis had inflammatory changes in a 
rectal biopsy, whilst this figure increased to 83 per cent 
when the patient had predominantly left-sided colitis and a 
normal rectum (Table 7). Thus the presence of microscopic 
rectal inflammatory changes is generally related to the 
proximity of grossly demonstrable disease. This finding has 
been documented before (28,44). 
Similarly, a statistically significant increase in aphthous 
ulceration was found in biopsies from macroscopically normal 
rectums in patients with colonic involvement, compared to 
patients with more proximal disease (P < 0.04) (Table 7). 
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(iii) Diagnostic value of rectal biopsy: 
Rectal biopsy is a relatively simple technique with few 
complications (47). Yet, its value in the diagnosis of Crohn's 
disease is still controversial. In the presence of rectal 
disease, Lockhart-Mummery and Morson were able to confirm the 
diagnosis in 16 out of 19 cases (61). However, Korelitz and 
Sommers found histologic attributes of Crohn's disease in 30 
per cent of rectal biopsy specimens of a sigmoidoscopically 
normal appearing rectal segment (44). Dyer et al found 
diagnostic features in 23 per cent of rectal biopsies (28). 
Some authors recommend serial sectioning of rectal biopsies to 
increase the diagnostic yield (35,36). However, this is a time 
consuming procedure and is not always easy to perform in busy 
surgical diagnostic laboratories. 
In contrast to these reports, Anderson and Bogoch found non-
specific inflammatory changes in 43 per cent of rectal 
biopsies in patients with Crohn's ileitis, but no granulomas 
were seen (41). In their series of patients with Crohn's 
colitis, McGovern and Goulston found rectal biopsy unhelpful 
(53). Hill et al examined a large amount of material from the 
National Cooperative Crohn's Disease Study group and found 
that a single random rectal biopsy was of extremely limited 
diagnostic use in Crohn's disease (27). 
As can be seen, divergent views abound as to whether rectal 
biopsy is of benefit or not. Our figures show that, taking 61 
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rectal biopsies, diagnostic or highly suggestive features were 
seen in 28 of the cases (46 per cent) (Table 8) (this figure 
includes the presence of granulomas). 
In the absence of granulomas, inflammatory changes highly 
suggestive of Crohn's disease were present in 25 cases (41%) 
in total (Table BA). When the rectum was involved 
macroscopically (11 cases) these features were found in 27 per 
cent (Table BB). An intriguing stastistic is that even in a 
macroscopically normal appearing rectum, helpful features in 
confirming the diagnosis were found in 44 per cent of cases 
(Table 8B). 
The question remains as to the usefulness of rectal biopsy in 
the diagnosis of Crohn's disease and whether it should be 
performed routinely even in a normal appearing rectum. Our 
figures would seem to indicate that a routine biopsy of the 
rectum still appears to be a worthwhile procedure in the 
diagnosis of Crohn's disease and tends to disagree with Hill 
et al's conclusions (27). Even a normal rectal biopsy may 
still be of value, as this finding in the presence of a 
definite case of colitis is very suggestive of Crohn's disease 
( 38) • 
(iv) Correlation of inflammatory changes with the CDAI: 
Once again comparison of the microscopic findings in rectal 
biopsies, including the presence of ulceration, aphthous 
ulceration, mucin depletion, "active" inflammation such as 
69 
cryptitis and crypt abscesses with the NCCD activity index 
revealed no statistical correlation. (Table 9A - F). These 
findings are similar to those found in colonoscopic biopsies. 
CONCLUSIONS: 
This dissertation has set out to document a number of 
histological findings in the initial presenting p~thological 
specimen in a group of known Crohn's disease patients. A 
mixture of resection specimens, colonoscopic and isolated 
rectal biopsies have been carefully studied. A control group 
of an equal number of specimens from unselected patients 
without Crohn's disease has not been a part of this study and 
this clearly does not allow us to make comparisons with other 
types of inflammatory bowel disease; however, conclusions that 
do not depend on such comparisons are valid and are the 
subject of this dissertation. 
Important new findings recorded here include the fact that 
microgranulomas are confined to the mucosal layer of the 
intestine and were not demonstrated in any other layers. 
Although previous authors have concluded that they are 
precursors to the more mature epithelioid granulomas, our 
results suggest that at least in the deeper layers they seem 
to be unrelated (43). This might be explained by the fact that 
there are two types of granulomas in Crohn's disease and the 
formation of granulomas in the mucosal layer is somehow 
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different to that in other layers of the intestinal wall. The 
aetiology and pathogenesis of both granulomas and 
microgranulomas needs further research and elucidation. 
The clinical course of Crohn's disease tends to be a 
progressive one and microscopic features which might predict 
clinical behaviour are of obvious importance. In our series we 
found no statistical correlation between any of the 
microscopic features examined and the Crohn's Disease Activity 
Index. The usual histological features that pathologists 
recognise as indicating microscopic evidence of disease 
activity therefore correlate very poorly with clinical 
assessment of disease activity and new criteria may need to be 
designed to indicate "active" disease. 
The value of rectal biopsy in the diagnosis of Crohn's disease 
has been extensively investigated (27-30,36,41~47,63,66,67). 
Our findings endorse the view of those who feel that this is a 
useful procedure and we would encourage physicians to perform 
rectal biopsy even in the situation where the rectum appears 
normal macroscopically. 
Despite all the results described in this dissertation, it 
still remains a basic principle that accurate diagnoses in 
medicine can only be made with good cooperation between all 
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